Predictive Oncology (NASDAQ:AGPU) Posts Quarterly Earnings Results

Predictive Oncology (NASDAQ:AGPU) announced its earnings results on Friday. The company reported ($0.36) EPS for the quarter, FiscalAI reports. The firm had revenue of $0.04 million for the quarter.

Predictive Oncology Stock Up 4.5%

NASDAQ AGPU traded up $0.25 during trading hours on Friday, reaching $5.85. 301,312 shares of the company were exchanged, compared to its average volume of 2,336,857. Predictive Oncology has a 1 year low of $1.03 and a 1 year high of $32.10. The firm has a 50 day simple moving average of $3.78. The company has a market cap of $32.41 million, a PE ratio of -0.46 and a beta of 3.45.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Predictive Oncology in a report on Friday, April 24th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Predictive Oncology currently has a consensus rating of “Sell”.

About Predictive Oncology

Predictive Oncology (NASDAQ: AGPU) is a biotechnology company focused on oncology-related research and product development that combines laboratory science with data analytics. The company positions itself to support precision medicine by applying computational methods and laboratory testing to better understand tumor biology and to accelerate the identification and development of oncology therapeutics and diagnostics.

Its activities include laboratory-based testing and analytic services intended to inform drug discovery and development, biomarker identification, and patient stratification efforts.